RadarScreener › CXAI

CXAI

CXApp Inc.
CXAI stock: delisting risk, reverse split — what the SEC filings say, updated every weekday morning.
Nasdaq · Services-Prepackaged Software · EDGAR filings (CIK 1820875) · 4 signals · 1 setups · updated Sep 18, 2026

What the filings say Pressure ▼

Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25.

Radar 80 (high attention) · dilution pressure low · listing risk high · governance risk low · runway n/a · strongest signal: Exchange deficiency notice (Sep 3, 2026)

What would confirm: Nasdaq 'Pending Suspension' listing, Form 25, hearings-panel denial 8-K, or a reverse-split proxy.
What would prove it wrong: 8-K announcing regained compliance; equity raise that restores stockholders' equity; MVLS back above threshold for 10+ days.

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on CXAI — free
One email every weekday morning: what changed across CXAI and ~1,400 other microcaps, every claim linked to the filing.
80Radar · attention score (0–100)
0Dilution pressure · financing + balance sheet
84Listing risk · exchange standards
0Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Listing cliff Pressure ▼ strength 0.80

Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.

Would confirm: Nasdaq 'Pending Suspension' listing, Form 25, hearings-panel denial 8-K, or a reverse-split proxy.
Would invalidate: 8-K announcing regained compliance; equity raise that restores stockholders' equity; MVLS back above threshold for 10+ days.
Delisting languageExchange deficiency noticeMinimum bid deficiencyReverse split

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on CXAI
Alerts
One email the morning CXAI files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for CXAI back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 910 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

n/acash + short-term investments
n/aestimated runway (no OCF data)
n/astockholders' equity
$22.9Mpublic float (10-K cover)
n/ashares outstanding

Runway = liquidity ÷ monthly operating burn at the latest reported period. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Sep 3, 2026 Exchange deficiency notice 8-K Item 3.01 filed 2026-09-03 (accepted 08:05 ET) filing 55
Sep 3, 2026 Minimum bid deficiency “min bid” language in 8-K (EX-99.2) filed 2026-09-03 filing 48
Sep 3, 2026 Delisting language “delisting notice” language in 8-K (EX-99.1) filed 2026-09-03 filing 46
Sep 3, 2026 Reverse split “reverse split” language in 8-K (EX-99.1) filed 2026-09-03 filing 34

Other listing cliff setups

AUID authID Inc. · SOBR SOBR Safe, Inc. · DAIC CID Holdco, Inc. · DFLI Dragonfly Energy Holdings Co · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans